However GI & health performance weaker than predicted
Aviva's life business (up 9% from 2016) performed 6% better than the Goldman Sachs estimate and 5% better than consensus, while GI & health was down (-16%) to £700m (from £833m last year). Life profits were £2,882m for the year (up from £2,642m in 2016) supported by a +£86m benefit (vs £50m last year) from the annuity business's increasing concentration of illiquids within its asset mix and £290m related to longevity assumption changes. The firm said it was encouraged by new business growth...
Is artificial intelligence the answer to the NHS crisis?
Larger sample size to follow
‘To better the insurance industry and improve customer outcomes’
Tim & Tracey’s story